ENO2 and neoplasm: In addition, we detected the levels of tumor biomarkers in LUAD (Fig. 3D) and found that the levels of TMED2, CEA, NSE, and EGFR in the sh-TMED2 group were reduced (P < 0.05, Fig. 3E).